Patient-derived 3D tumor organoids that keep the architecture and heterogeneity of the original tumor. Cryopreserved; genomic match to the source tumor confirmed. Research use only.
$1,000
| Tumor type | Prostate Adenocarcinoma |
| Species | Human |
| Tissue source | Fresh tumor tissue |
| Max recommended passages / lifespan | TBD – how many passages can the buyer expand it? |
| Post-thaw viability (guaranteed min %) | ≥ 50% post-thaw (website) |
| Cells per vial | TBD – cells or organoids per vial? (ATCC sells ≥ 1 × 10^6 cells) |
| Freezing medium | CryoStor (website) |
| Recommended culture medium | TBD – medium AND matrix (e.g. basement-membrane gel) needed |
| Medium kit available? | TBD |
| Storage on arrival | ≤ −150 °C (website) |
| Ships as | Frozen, on dry ice (website) |
| Biosafety level | BSL-2 (website) |
| Donor data provided | Website: 'comprehensive clinical reports', 'clinical metadata intact'. Which fields exactly? |
| Marker panel | 'Biomarker authentication' (website) – which markers? |
| Mycoplasma test | Included (website: 'all models include … mycoplasma testing') |
| Certificate of Analysis (CoA) | Included – template needed |
| Intended use | Research Use Only. Not for use in humans or for diagnostic procedures. |
| Consent covers commercial sale of derived cells? | TBD (website says 'IRB-approved' – consent scope still unknown) |
